Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06283329Completed

Residual Vocal Cords Curarization Correlation Between Clinical and Ultrasound Endpoints

Role: lead

NCT06021912Unknown

e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma

Role: lead

NCT05993312Unknown

Quality of Life in Traumatic Brain Injury Patients

Role: lead

NCT05822180Phase 3Completed

Evaluation of the Efficacy and Safety of Nano-S1

Role: lead

NCT05516173Unknown

Role of Depression in Blood Pressure Control. Study

Role: lead

NCT05516446Not ApplicableUnknown

Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent

Role: lead

NCT05311111Not ApplicableUnknown

Efficacy and Safety of the Distal Radial Approach

Role: lead

NCT04472780Not ApplicableUnknown

Hyperbaric Oxygen Treatment in Autism Spectrum Disorders

Role: lead

NCT04924855Unknown

Immunity After COVID-19 Vaccination

Role: lead

NCT04740125Completed

SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY

Role: lead

All 10 trials loaded